AMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ameriprise Financial (AMP) is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy, especially if the goal is to act now rather than wait for a better entry. The stock is technically weak, with bearish moving averages, a negative MACD that is still worsening, and price sitting below the pivot level. While analyst targets have generally moved higher after a solid earnings beat, the ratings are mixed and not strongly bullish overall. Options sentiment is mildly constructive, but not enough to override the current technical weakness and cautious insider/congress activity. Overall, this is a hold, not an immediate buy.
AMP closed at 439.79, slightly below the prior close and below the pivot level of 457.539. The moving average structure is bearish (SMA_200 > SMA_20 > SMA_5), which signals a downtrend or weak momentum. MACD histogram is -3.455 and negatively expanding, showing bearish momentum is still intensifying. RSI_6 at 20.918 indicates the stock is oversold, but not yet showing a confirmed reversal. Key support is around 442.051 (S1) and 432.483 (S2), while resistance starts at 473.028 (R1). The short-term pattern data also points to near-term weakness, with an 80% chance of -2.34% next day, even though the medium-term outlook improves later.
Recent analyst target increases after Q1 earnings beat show improving fundamental expectations. Piper Sandler, Morgan Stanley, BofA, BMO, and Evercore all revised targets higher in recent weeks. The company reportedly beat adjusted operating EPS expectations, supported by higher revenue and better operating margins. Options sentiment is mildly bullish, and the company still has a solid Advice & Wealth Management franchise. The stock trend model also suggests better performance over the next week and month than the next day.
No news in the last week means there is no fresh catalyst driving the shares higher right now. Analyst views remain mixed, with Neutral, Underweight, and Market Perform ratings still present despite higher targets. Morgan Stanley continues to hold an Underweight stance, and several firms note margin peak concerns, advisor competition, and possible estimate risk. Hedge funds and insiders are neutral, with no strong accumulation trend. Congress trading leans cautious, with more sales than purchases over the last 90 days. Technicals are bearish and momentum is deteriorating.
Latest quarter: Q1 2026. The company posted an adjusted operating EPS beat, driven by higher revenue and better operating margins, which came in at 28% and exceeded expectations. That indicates strong recent profitability and solid earnings quality. However, commentary from analysts suggests net new assets may remain low over the next couple of quarters as Comerica-related assets continue transitioning, which could limit near-term growth.
Recent analyst activity is mixed but slightly more constructive on price targets after Q1 results. Targets were raised by Piper Sandler ($471), Morgan Stanley ($467), BofA ($594), BMO ($490), and Evercore ISI ($589), but ratings remain split between Buy, Neutral, Market Perform, In Line, and Underweight. The Wall Street pros view is therefore balanced rather than clearly bullish: bulls point to the earnings beat, margin strength, and resilient advice/wealth management, while bears focus on advisor competition, peak margins, and forward estimate risk.
